Apolipoprotein D modulates amyloid pathology in APP/PS1 Alzheimer's disease mice

Neurobiology of Aging
Hongyun LiBrett Garner

Abstract

Apolipoprotein D (apoD) is expressed in the brain and levels are increased in affected brain regions in Alzheimer's disease (AD). The role that apoD may play in regulating AD pathology has not been addressed. Here, we crossed both apoD-null mice and Thy-1 human apoD transgenic mice with APP-PS1 amyloidogenic AD mice. Loss of apoD resulted in a nearly 2-fold increase in hippocampal amyloid plaque load, as assessed by immunohistochemical staining. Conversely, transgenic expression of neuronal apoD reduced hippocampal plaque load by approximately 35%. This latter finding was associated with a 60% decrease in amyloid β 1-40 peptide levels, and a 34% decrease in insoluble amyloid β 1-42 peptide. Assessment of β-site amyloid precursor protein cleaving enzyme-1 (BACE1) levels and proteolytic products of amyloid precursor protein and neuregulin-1 point toward a possible association of altered BACE1 activity in association with altered apoD levels. In conclusion, the current studies provide clear evidence that apoD regulates amyloid plaque pathology in a mouse model of AD.

References

Dec 1, 1996·Genetic Analysis : Biomolecular Engineering·D R BorcheltD L Price
Jun 25, 1999·Brain Research. Molecular Brain Research·L TerrisseE Rassart
Nov 4, 2000·Biochimica Et Biophysica Acta·E RassartR Milne
Dec 24, 2002·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Purnima P DesaiM Ilyas Kamboh
Aug 19, 2004·Journal of Neurology·Seppo HelisalmiHilkka Soininen
Jan 15, 2005·Neurobiology of Disease·Katrin SchuesselAnne Eckert
Oct 13, 2006·Neurobiology of Disease·Monica Garcia-AllozaMatthew P Frosch
Nov 14, 2006·Nature Neuroscience·Xiangyou HuRiqiang Yan
May 5, 2007·Biochimica Et Biophysica Acta·Sonia Do CarmoEric Rassart
May 23, 2007·Aging Cell·Wulf Dröge, Hyman M Schipper
Jul 27, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Alfonso LagaresCarlos Avendaño
Jan 19, 2008·The Journal of Clinical Investigation·Suzanne E WahrleDavid M Holtzman
May 7, 2008·Proceedings of the National Academy of Sciences of the United States of America·Julien MuffatSeymour Benzer
Jun 20, 2008·Journal of Neuroinflammation·Magdalena SastreSteve M Gentleman
Sep 3, 2008·Free Radical Biology & Medicine·Hafiz Mohmmad AbdulD Allan Butterfield
Oct 10, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Sonia Do CarmoEric Rassart
Jan 30, 2009·American Journal of Physiology. Endocrinology and Metabolism·Sonia Do CarmoEric Rassart
Aug 28, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Ping YanJin-Moo Lee
Feb 9, 2010·Nature Reviews. Neurology·Bart De StrooperTodd Golde
Jun 18, 2010·Biochimica Et Biophysica Acta·Rene O Sanchez-Mejia, Lennart Mucke
Mar 23, 2011·Clinical Lipidology·David A ElliottBrett Garner
Apr 6, 2011·Journal of Neurochemistry·Raquel Bajo-GrañerasMaria D Ganfornina
Mar 30, 2012·Current Alzheimer Research·Daniel FleckMichael Willem
May 3, 2013·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Daniel FleckChristian Haass
Mar 13, 2014·Neurobiology of Aging·Sarah DassatiRüdiger Schweigreiter

❮ Previous
Next ❯

Citations

Dec 12, 2018·Journal of Alzheimer's Disease : JAD·André de Macêdo Medeiros, Regina Helena Silva
Nov 24, 2018·Journal of Molecular Neuroscience : MN·Surabhi BhatiaGlenda M Halliday
Sep 6, 2019·Medicines·Patricia ReganMargaret Doherty
Sep 6, 2020·Journal of Neurochemistry·Steve PedriniRalph N Martins
Jan 6, 2021·Bioscience Reports·Claudia S KielkopfSimon H J Brown
Apr 15, 2020·Journal of Controlled Release : Official Journal of the Controlled Release Society·Raghavendra UpadhyaAshok K Shetty
Jun 20, 2020·Gene·Eric RassartCatherine Mounier
Oct 26, 2021·Frontiers in Physiology·Diego Sanchez, Maria D Ganfornina

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: APOE

Apolipoprotein E (APOE) polymorphic alleles are major genetic risk factors for Alzheimer's disease. Discover the latest research on APOE and other genetic determinants of Alzheimer's disease here.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: Animal Models

Alzheimer's disease is a neurodegenerative disease which can be studied using various experimental systems. This feed focuses on animal models used for Alzheimer's disease research.